BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1345 related articles for article (PubMed ID: 19935649)

  • 1. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
    Wellner U; Schubert J; Burk UC; Schmalhofer O; Zhu F; Sonntag A; Waldvogel B; Vannier C; Darling D; zur Hausen A; Brunton VG; Morton J; Sansom O; Schüler J; Stemmler MP; Herzberger C; Hopt U; Keck T; Brabletz S; Brabletz T
    Nat Cell Biol; 2009 Dec; 11(12):1487-95. PubMed ID: 19935649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
    Burk U; Schubert J; Wellner U; Schmalhofer O; Vincan E; Spaderna S; Brabletz T
    EMBO Rep; 2008 Jun; 9(6):582-9. PubMed ID: 18483486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
    Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
    J Biol Chem; 2014 Feb; 289(7):4116-25. PubMed ID: 24371144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster.
    Li XL; Hara T; Choi Y; Subramanian M; Francis P; Bilke S; Walker RL; Pineda M; Zhu Y; Yang Y; Luo J; Wakefield LM; Brabletz T; Park BH; Sharma S; Chowdhury D; Meltzer PS; Lal A
    Mol Cell Biol; 2014 Feb; 34(3):533-50. PubMed ID: 24277930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M; Lee ES; Hu G; Kang Y
    J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
    Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
    J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.
    Sundararajan V; Gengenbacher N; Stemmler MP; Kleemann JA; Brabletz T; Brabletz S
    Oncotarget; 2015 Sep; 6(29):27083-96. PubMed ID: 26334100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 11. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.
    Brabletz S; Bajdak K; Meidhof S; Burk U; Niedermann G; Firat E; Wellner U; Dimmler A; Faller G; Schubert J; Brabletz T
    EMBO J; 2011 Feb; 30(4):770-82. PubMed ID: 21224848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.
    Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
    J Biol Chem; 2013 Apr; 288(16):11572-80. PubMed ID: 23443660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
    Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
    Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.
    Al-Khalaf HH; Aboussekhra A
    J Biol Chem; 2014 Nov; 289(45):31433-47. PubMed ID: 25261470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.